Actinium Pharmaceuticals, Inc. (ATNM)
Net Income
$27.90M
Quarterly · Period ending: · USD
ATNM Net Income
Latest reported$27.90Mperiod ending
Latest reported$27.90Mperiod ending
ATNM Quarterly Net Income (-$9.81K → $27.90M)
Quarterly net income
High-resolution chart · PNG
ATNM net income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income (USD) |
|---|---|
| 27,901,000 | |
| -5,522,000 | |
| -5,940,000 | |
| -5,131,000 | |
| -6,878,000 | |
| -15,938,000 | |
| -6,652,000 | |
| -11,568,000 | |
| -11,353,000 | |
| -8,670,000 | |
| -9,324,000 | |
| -13,276,000 | |
| -15,181,000 | |
| -11,037,000 | |
| -10,647,000 | |
| -9,474,000 | |
| -7,767,000 | |
| -5,129,000 | |
| -8,010,000 | |
| -6,423,000 | |
| -5,021,000 | |
| -5,320,000 | |
| -6,380,000 | |
| -5,540,000 | |
| -4,625,000 | |
| -5,670,000 | |
| -4,602,435 | |
| -6,599,000 | |
| -5,027,000 | |
| -5,670,000 | |
| -6,320,000 | |
| -6,148,000 | |
| -4,863,000 | |
| -6,314,000 | |
| -5,163,000 | |
| -6,323,000 | |
| -7,054,000 | |
| -8,062,000 | |
| -6,696,000 | |
| -6,599,000 | |
| -6,624,000 | |
| -4,403,000 | |
| -6,541,000 | |
| -3,946,000 | |
| -7,464,000 | |
| -3,075,000 | |
| -5,426,000 | |
| -6,077,000 | |
| 3,515,000 | |
| -16,699,000 | |
| -5,880,000 | |
| -1,421,000 | |
| -2,784,000 | |
| -689,000 | |
| -8,342,000 | |
| -3,012,000 | |
| -1,563,000 | |
| -908,909 | |
| -2,647 | |
| -3,514 | |
| 20,455 | |
| -4,005 | |
| -8,522 | |
| -9,679 | |
| 28,171 | |
| -8,296 | |
| -9,497 | |
| -3,849 | |
| -3,672 | |
| -5,313 | |
| -7,612 | |
| -3,330 | |
| -9,473 | |
| -10,828 | |
| -4,637 | |
| -6,353 | |
| -3,375 | |
| -435 | |
| -8,374 | |
| -9,812 |